{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:43:59Z","timestamp":1792338239914,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,18]]},"DOI":"10.7759\/cureus.118111","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:06:52Z","timestamp":1792336012000},"source":"Crossref","is-referenced-by-count":0,"title":["Safety and Effectiveness of Bupropion for Smoking Cessation During Pregnancy: A Scoping Review"],"prefix":"10.7759","author":[{"given":"George R","family":"Habib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Garas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"ZYBAN (bupropion hydrochloride) sustained-release tablets, for oral use. initial U.S. approval: 1985. (2021). Accessed: September 9, 2026: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/020711s052lbl.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003822","article-title":"Tobacco and nicotine cessation during pregnancy: ACOG Committee Opinion, Number 807","volume":"135","year":"2020","unstructured":"Tobacco and nicotine cessation during pregnancy. ACOG Committee Opinion, Number 807. Obstet Gynecol. 2020, 135:e221-9. 10.1097\/AOG.0000000000003822","journal-title":"Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000031.pub6","article-title":"Antidepressants for smoking cessation","volume":"5","author":"Hajizadeh A","year":"2023","unstructured":"Hajizadeh A, Howes S, Theodoulou A, Klemperer E, Hartmann-Boyce J, Livingstone-Banks J, Lindson N. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2023, 5:CD000031. 10.1002\/14651858.CD000031.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjc.2018.09.001","article-title":"Smoking cessation strategies in pregnancy: current concepts and controversies","volume":"60","author":"Ioakeimidis N","year":"2019","unstructured":"Ioakeimidis N, Vlachopoulos C, Katsi V, Tousoulis D. Smoking cessation strategies in pregnancy: current concepts and controversies. Hellenic J Cardiol. 2019, 60:11-5. 10.1016\/j.hjc.2018.09.001","journal-title":"Hellenic J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.09.027","article-title":"Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study","volume":"192","author":"Chun-Fai-Chan B","year":"2005","unstructured":"Chun-Fai-Chan B, Koren G, Fayez I, et al.. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol. 2005, 192:932-6. 10.1016\/j.ajog.2004.09.027","journal-title":"Am J Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1296","article-title":"Bupropion in pregnancy and the prevalence of congenital malformations","volume":"16","author":"Cole JA","year":"2007","unstructured":"Cole JA, Modell JG, Haight BR, Cosmatos IS, Stoler JM, Walker AM. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf. 2007, 16:474-84. 10.1002\/pds.1296","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3661","article-title":"First-trimester exposure to bupropion and risk of cardiac malformations","volume":"23","author":"Louik C","year":"2014","unstructured":"Louik C, Kerr S, Mitchell AA. First-trimester exposure to bupropion and risk of cardiac malformations. Pharmacoepidemiol Drug Saf. 2014, 23:1066-75. 10.1002\/pds.3661","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010078.pub3","article-title":"Pharmacological interventions for promoting smoking cessation during pregnancy","volume":"3","author":"Claire R","year":"2020","unstructured":"Claire R, Chamberlain C, Davey MA, Cooper SE, Berlin I, Leonardi-Bee J, Coleman T. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2020, 3:CD010078. 10.1002\/14651858.CD010078.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/nty055","article-title":"Systematic review and meta-analysis to assess the safety of bupropion and varenicline in pregnancy","volume":"21","author":"Turner E","year":"2019","unstructured":"Turner E, Jones M, Vaz LR, Coleman T. Systematic review and meta-analysis to assess the safety of bupropion and varenicline in pregnancy. Nicotine Tob Res. 2019, 21:1001-10. 10.1093\/ntr\/nty055","journal-title":"Nicotine Tob Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.46658\/JBIMES-24-09","article-title":"Scoping reviews (2026)","author":"Pollock D","year":"2024","unstructured":"Pollock D, Peters MD, Tricco AC, et al.. Scoping reviews (2026). JBI Manual for Evidence Synthesis. Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z (ed): JBI, Adelaide, Australia; 2024. 10.46658\/JBIMES-24-09"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco AC","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al.. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018, 169:467-73. 10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani M","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016, 5:210. 10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0693-0","article-title":"Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000","volume":"59","author":"Boshier A","year":"2003","unstructured":"Boshier A, Wilton LV, Shakir SA. Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000. Eur J Clin Pharmacol. 2003, 59:767-73. 10.1007\/s00228-003-0693-0","journal-title":"Eur J Clin Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2003.10.260","article-title":"Bupropion SR for smoking cessation in pregnancy: a pilot study","volume":"189","author":"Miller H","year":"2003","unstructured":"Miller H, Ranger-Moore J, Hingtgen M. Bupropion SR for smoking cessation in pregnancy: a pilot study. Am J Obstet Gynecol. 2003, 189:S133. 10.1016\/j.ajog.2003.10.260","journal-title":"Am J Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1300\/J069v24n02_02","article-title":"Effectiveness of bupropion for smoking cessation during pregnancy","volume":"24","author":"Chan B","year":"2005","unstructured":"Chan B, Einarson A, Koren G. Effectiveness of bupropion for smoking cessation during pregnancy. J Addict Dis. 2005, 24:19-23. 10.1300\/J069v24n02_02","journal-title":"J Addict Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/00952990903544844","article-title":"The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse","volume":"36","author":"Chisolm MS","year":"2010","unstructured":"Chisolm MS, Brigham EP, Tuten M, Strain EC, Jones HE. The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse. Am J Drug Alcohol Abuse. 2010, 36:46-51. 10.3109\/00952990903544844","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2012.671119","article-title":"Using a multidisciplinary approach for pregnant women with nicotine dependence and co-occurring disorders","volume":"8","author":"Lundquist RS","year":"2012","unstructured":"Lundquist RS, Seward G, Byatt N, Tonelli ME, Kolodziej ME. Using a multidisciplinary approach for pregnant women with nicotine dependence and co-occurring disorders. J Dual Diagn. 2012, 8:158-67. 10.1080\/15504263.2012.671119","journal-title":"J Dual Diagn"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1386635","article-title":"Randomized, controlled pilot trial of bupropion for pregnant smokers: challenges and future directions","volume":"32","author":"Stotts AL","year":"2015","unstructured":"Stotts AL, Northrup TF, Cinciripini PM, et al.. Randomized, controlled pilot trial of bupropion for pregnant smokers: challenges and future directions. Am J Perinatol. 2015, 32:351-6. 10.1055\/s-0034-1386635","journal-title":"Am J Perinatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.06.059","article-title":"Success of smoking cessation interventions during\u00a0pregnancy","volume":"215","author":"B\u00e9rard A","year":"2016","unstructured":"B\u00e9rard A, Zhao JP, Sheehy O. Success of smoking cessation interventions during\u00a0pregnancy. Am J Obstet Gynecol. 2016, 215:611.e1-8. 10.1016\/j.ajog.2016.06.059","journal-title":"Am J Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.11.1036","article-title":"Bupropion sustained release for pregnant smokers: a\u00a0randomized, placebo-controlled trial","volume":"216","author":"Nanovskaya TN","year":"2017","unstructured":"Nanovskaya TN, Oncken C, Fokina VM, et al.. Bupropion sustained release for pregnant smokers: a\u00a0randomized, placebo-controlled trial. Am J Obstet Gynecol. 2017, 216:420.e1-9. 10.1016\/j.ajog.2016.11.1036","journal-title":"Am J Obstet Gynecol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1472-9","article-title":"Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study","volume":"18","author":"Tran DT","year":"2020","unstructured":"Tran DT, Preen DB, Einarsdottir K, et al.. Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study. BMC Med. 2020, 18:15. 10.1186\/s12916-019-1472-9","journal-title":"BMC Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2021.100315","article-title":"Placebo-controlled trial of bupropion for smoking cessation in pregnant women","volume":"3","author":"Kranzler HR","year":"2021","unstructured":"Kranzler HR, Washio Y, Zindel LR, et al.. Placebo-controlled trial of bupropion for smoking cessation in pregnant women. Am J Obstet Gynecol MFM. 2021, 3:100315. 10.1016\/j.ajogmf.2021.100315","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.0290","article-title":"Risk of major congenital malformations following prenatal exposure to smoking cessation medicines","volume":"185","author":"Tran DT","year":"2025","unstructured":"Tran DT, Cohen JM, Donald S, et al.. Risk of major congenital malformations following prenatal exposure to smoking cessation medicines. JAMA Intern Med. 2025, 185:656-67. 10.1001\/jamainternmed.2025.0290","journal-title":"JAMA Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/add.70290","article-title":"Effectiveness of smoking cessation pharmacotherapies during pregnancy: a multi-national population-based study","volume":"121","author":"Robijn AL","year":"2026","unstructured":"Robijn AL, Donald S, Cohen JM, et al.. Effectiveness of smoking cessation pharmacotherapies during pregnancy: a multi-national population-based study. Addiction. 2026, 121:1112-27. 10.1111\/add.70290","journal-title":"Addiction"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/515390-safety-and-effectiveness-of-bupropion-for-smoking-cessation-during-pregnancy-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:06:53Z","timestamp":1792336013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/515390-safety-and-effectiveness-of-bupropion-for-smoking-cessation-during-pregnancy-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,18]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.118111","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,18]]}}}